| 000 | 01667 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513051131.0 | ||
| 264 | 0 | _c19931227 | |
| 008 | 199312s 0 0 eng d | ||
| 022 | _a0008-543X | ||
| 024 | 7 |
_a10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLum, B L | |
| 245 | 0 | 0 |
_aClinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations. _h[electronic resource] |
| 260 |
_bCancer _cDec 1993 |
||
| 300 |
_a3502-14 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 | _aATP Binding Cassette Transporter, Subfamily B, Member 1 |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacokinetics |
| 650 | 0 | 4 |
_aCarrier Proteins _xgenetics |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Resistance _xgenetics |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aGene Expression Regulation, Neoplastic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xgenetics |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 700 | 1 | _aFisher, G A | |
| 700 | 1 | _aBrophy, N A | |
| 700 | 1 | _aYahanda, A M | |
| 700 | 1 | _aAdler, K M | |
| 700 | 1 | _aKaubisch, S | |
| 700 | 1 | _aHalsey, J | |
| 700 | 1 | _aSikic, B I | |
| 773 | 0 |
_tCancer _gvol. 72 _gno. 11 Suppl _gp. 3502-14 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n _zAvailable from publisher's website |
| 999 |
_c7901540 _d7901540 |
||